<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>367-AGONIST-ANTAGONIST-OPIOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AGONIST-ANTAGONIST OPIOIDS " code="NO2A-001" /></DRUG1>
<DRUG2>
<CLASS name="STEP II OPIOID ANALGESICS" code="N02A-003" /></DRUG2>
<DESCRIPTION>Decrease of the antalgic effect due to competitive blocking of the receptors, with risk of appearance of a withdrawal syndrome. </DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>367-AGONIST-ANTAGONIST-OPIOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AGONIST-ANTAGONIST OPIOIDS " code="NO2A-001" /></DRUG1>
<DRUG2>
<CLASS name="STEP III OPIOID ANALGESICS" code="N02A-002" /></DRUG2>
<DESCRIPTION>Decrease of the antalgic effect due to competitive blocking of the receptors, with risk of appearance of a withdrawal syndrome</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>367-AGONIST-ANTAGONIST-OPIOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AGONIST-ANTAGONIST OPIOIDS " code="NO2A-001" /></DRUG1>
<DRUG2>
<CLASS name="TRUE MORPHINE ANTITUSSIVES" code="R0GDA0-002" /></DRUG2>
<DESCRIPTION>Decrease of the antalgic or antitussive effect of the opioid, due to competitive blocking of the receptors, with risk of appearance of a withdrawal syndrome</DESCRIPTION>
<SEVERITY>Not recommended </SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>367-AGONIST-ANTAGONIST-OPIOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AGONIST-ANTAGONIST OPIOIDS " code="NO2A-001" /></DRUG1>
<DRUG2>
<DRUG name="METHADONE" rxcui="6813">
<ATC code="N07BC02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the effect of the methadone due to competitive blocking of the receptors</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>367-AGONIST-ANTAGONIST-OPIOIDS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="AGONIST-ANTAGONIST OPIOIDS " code="NO2A-001" /></DRUG1>
<DRUG2>
<CLASS name="PARTIAL AGONIST OPIOIDS" code="PARAG" /></DRUG2>
<DESCRIPTION>Risk of decrease of the antalgic effect and/or of appearance of a withdrawal syndrome</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
